Sumitovant Biopharma Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 322,328 shares at $22.04 ($7.1M) on 2021-09-14, disclosed to the SEC on 2021-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.04 | 65,128 | $1.4M | 20.2% |
| 2 | $22.04 | 65,128 | $1.4M | 20.2% |
| 3 | $22.76 | 6,172 | $140K | 2.0% |
| 4 | $22.76 | 6,172 | $140K | 2.0% |
| 5 | $21.98 | 89,864 | $2.0M | 27.8% |
| 6 | $21.98 | 89,864 |
| $2.0M |
| 27.8% |
| Total | $22.03 avg | 322,328 | $7.1M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-08 | $3.4M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |
| MYOV | BUY | 2021-08-24 | $4.4M | — | Filing → |